Clinical Trials Directory

Trials / Completed

CompletedNCT04583202

Evaluation of the Nasal and Conjunctival Response in Subjects Allergic to Birch Pollen in the ALYATEC Environmental Exposure Chamber

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Alyatec · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to assess the nasal and conjunctival response in subjects allergic to birch pollen during controlled exposures in the ALYATEC environmental exposure chamber (EEC)

Detailed description

This is a single-center, single-blind, placebo-controlled study. The first part of the study consists of 6 exposure sessions in Alyatec EEC, including placebo and birch pollen allergen exposures. The second part of the study involves in-field evaluations of rhinitis and conjunctivitis symptoms during birch pollen season. Alyatec environmental exposure chamber, also called allergen challenge chamber, allows to evaluate allergic symptoms in standardized and reproducible conditions. All the metrological parameters (temperature, air flow, hygrometry ...) are controlled as well as the allergen concentration diffused in the room. This enables to induce and observe rhinitis, conjunctivitis and asthma symptoms for up to 20 patients at the same time, in a reproducible way and without the potential perturbations or contaminations of the natural environment. The current study aims to get specific information about allergic symptoms induced in the Alyatec EEC chamber in patients sensitized to birch pollen allergen.

Conditions

Interventions

TypeNameDescription
OTHERExposure to placeboPatients are exposed to a placebo for 4h in the Alyatec EEC
OTHERExposure to allergenPatients are exposed to birch pollen allergens for 4h in the Alyatec EEC

Timeline

Start date
2020-02-24
Primary completion
2020-10-19
Completion
2021-05-31
First posted
2020-10-12
Last updated
2021-06-09

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04583202. Inclusion in this directory is not an endorsement.